Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
A 2025 study in Cell Metabolism confirmed that tirzepatide reduces calorie intake at meals by an estimated 524.6 calories compared to placebo
Morbid obesity : Cap the dose at 100 kg body weight
Lack of knowledge leads to suboptimal transformations
[1] [2] The pharmacokinetic properties of each medication determine its recommended dosing frequencysemaglutide and tirzepatide are typically administered once weekly due to their longer half-lives (approximately one week for semaglutide), whilst liraglutide has a shorter half-life (approximately 13 hours) and requires daily injections
Research on semaglutide (a related GLP-1 medication) shows that most patients regain significant weight after stopping, with the STEP-1 trial extension showing approximately two-thirds of lost weight regained within a year of stopping
